Filippatos G - Search Results

1

Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.

Packer M, Anker SD, Butler J, Filippatos G, Ferreira JP, Pocock SJ, Sattar N, Brueckmann M, Jamal W, Cotton D, Iwata T, Zannad F; EMPEROR-Reduced Trial Committees and Investigators. Packer M, et al. Among authors: filippatos g. J Am Coll Cardiol. 2021 Mar 23;77(11):1381-1392. doi: 10.1016/j.jacc.2021.01.033. J Am Coll Cardiol. 2021. PMID: 33736819 Free article. Clinical Trial.

2

Studies on apoptosis and fibrosis in skeletal musculature: a comparison of heart failure patients with and without cardiac cachexia.

Filippatos GS, Kanatselos C, Manolatos DD, Vougas B, Sideris A, Kardara D, Anker SD, Kardaras F, Uhal B. Filippatos GS, et al. Int J Cardiol. 2003 Jul;90(1):107-13. doi: 10.1016/s0167-5273(02)00535-1. Int J Cardiol. 2003. PMID: 12821225

3

B-type natriuretic peptide serum levels in acute heart failure.

Filippatos GS, Anker SD, Kardaras F. Filippatos GS, et al. Eur Heart J. 2004 Jun;25(12):1085; author reply 1085-6. doi: 10.1016/j.ehj.2004.03.027. Eur Heart J. 2004. PMID: 15191781 No abstract available.

4

Pathophysiology of peripheral muscle wasting in cardiac cachexia.

Filippatos GS, Anker SD, Kremastinos DT. Filippatos GS, et al. Curr Opin Clin Nutr Metab Care. 2005 May;8(3):249-54. doi: 10.1097/01.mco.0000165002.08955.5b. Curr Opin Clin Nutr Metab Care. 2005. PMID: 15809526 Review.

5

Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure.

Parissis JT, Panou F, Farmakis D, Adamopoulos S, Filippatos G, Paraskevaidis I, Venetsanou K, Lekakis J, Kremastinos DT. Parissis JT, et al. Among authors: filippatos g. Am J Cardiol. 2005 Aug 1;96(3):423-6. doi: 10.1016/j.amjcard.2005.03.092. Am J Cardiol. 2005. PMID: 16054474 Clinical Trial.

6

Prognosis and therapy approaches of cardiac cachexia.

Springer J, Filippatos G, Akashi YJ, Anker SD. Springer J, et al. Among authors: filippatos g. Curr Opin Cardiol. 2006 May;21(3):229-33. doi: 10.1097/01.hco.0000221585.94490.09. Curr Opin Cardiol. 2006. PMID: 16601462 Review.

7

Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.

Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT. Adamopoulos S, et al. Am J Cardiol. 2006 Jul 1;98(1):102-6. doi: 10.1016/j.amjcard.2006.01.068. Epub 2006 May 6. Am J Cardiol. 2006. PMID: 16784930 Clinical Trial.

8

Decompensated heart failure and cachexia: Is it time to legalize anabolics?

Filippatos G, Rauchhaus M, Anker SD. Filippatos G, et al. Int J Cardiol. 2006 Jul 28;111(1):185-6. doi: 10.1016/j.ijcard.2006.06.002. Epub 2006 Jul 7. Int J Cardiol. 2006. PMID: 16828897 No abstract available.

9

Effects of levosimendan on right ventricular function in patients with advanced heart failure.

Parissis JT, Paraskevaidis I, Bistola V, Farmakis D, Panou F, Kourea K, Nikolaou M, Filippatos G, Kremastinos D. Parissis JT, et al. Among authors: filippatos g. Am J Cardiol. 2006 Dec 1;98(11):1489-92. doi: 10.1016/j.amjcard.2006.06.052. Epub 2006 Oct 13. Am J Cardiol. 2006. PMID: 17126656 Clinical Trial.

10

Epidemiology of acute heart failure syndromes.

Alla F, Zannad F, Filippatos G. Alla F, et al. Among authors: filippatos g. Heart Fail Rev. 2007 Jun;12(2):91-5. doi: 10.1007/s10741-007-9009-2. Heart Fail Rev. 2007. PMID: 17450426 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

882 results

Search Page